Prevention and Reduction of Falls: Testing and Evaluating Cutting Edge Haptic Technology

Part of paid clinical trials in Mansfield, Texas.

Sponsor
SuperPatch Limited LLC
Study ID
NCT07781397
Status
Enrolling By Invitation

Conditions

  • Accidental Falls
  • Accidental Falls/Prevention & Control
  • Fall Risk
  • Fall Risk, Fall Prevention

Eligibility Criteria

Sex
ALL
Age
55 Years - 85 Years
Healthy Volunteers
Not accepted

Interventions

  • LIBERTY Patch — DEVICE
    A drug-free, non-invasive, investigational topical patch designed to assist with balance and mobility, worn daily for 7 days.
  • Sham Patch — DEVICE
    A visually identical patch without active technology, worn daily for 7 days under the same conditions as the active patch.

Study Details

This study evaluates whether a drug-free, non-invasive haptic patch (LIBERTY Patch) affects fall-risk classification and balance/mobility confidence in adults ages 55 to 85. Approximately 150 participants are assigned to wear either the active LIBERTY Patch or a visually identical sham patch daily for 7 days. Balance and mobility are assessed using the FallSkip wearable device and a Falls Efficacy Scale questionnaire at baseline and again after 7 days. Neither participants nor investigators know which patch is assigned during the study period, though this can be unblinded in an emergency.

Key Dates

First listed
Aug 24, 2026
Start date
Jun 16, 2025
Status verified
Aug 2026
Primary completion
Dec 31, 2026
Completion
Dec 31, 2026

Study Design

Enrollment
150 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION

Arms

  • Active Comparator: Active LIBERTY Patch (Vibrotactile/Haptic)
    Participants apply the active LIBERTY Patch (Haptic Vibrotactile Trigger Technology) daily for 7 days, with fall-risk/mobility assessment (FallSkip device) and Falls Efficacy Scale survey completed at baseline and Day 7.
  • Sham Comparator: Control (Sham Patch)
    Participants apply a visually identical sham patch without active technology daily for 7 days, with the same baseline and Day 7 assessments as the Active arm.

Primary Outcome Measure

Change in fall-risk/mobility assessment (FallSkip device) [ Time Frame: Baseline and Day 7 ]

Locations (1)

FacilityCityStateZIPSite coordinators
Anna Toker, MDMansfieldTexas76063-

Find similar trials in Mansfield, TX

Related Studies